Short term, low dose alpha-ketoglutarate based polymeric nanoparticles with methotrexate reverse rheumatoid arthritis symptoms in mice and modulate T helper cell responses. (3rd October 2022)

• Record Type: Journal Article
• Authors: Mangal, Joslyn L.; Inamdar, Sahil; Suresh, Abhirami P.; Jaggarapu, Madhan Mohan Chandra Sekhar; Esrafili, Arezoo; Ng, Nathan D.; Acharya, Abhinav P.
• Is Part Of: Biomaterials science. Volume 10:Number 23(2022)
• Page Start: 6688
• Page End: 6697
• Publication Date: 2022-10-03
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d2bm00415a
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Suppressive T cells induce anti-inflammatory responses in rheumatoid arthritis (RA) which then reverse inflammation of the joints. Abstract : Activated effector T cells induce pro-inflammatory responses in rheumatoid arthritis (RA) which then lead to inflammation of the joints. In this report, we demonstrate that polymeric nanoparticles with alpha keto-glutarate (aKG) in their polymer backbone (termed as paKG NPs) modulate T cell responses in vitro and in vivo . Impressively, a low dose of only three administrations of methotrexate, a clinically and chronically administered drug for RA, in conjunction with two doses of paKG NPs, reversed arthritis symptoms in collagen-induced arthritis (CIA) mice. This was further followed by significant decreases in pro-inflammatory antigen-specific T helper type 17 (TH 17) responses and a significant increase in anti-inflammatory regulatory T cell (TREG ) responses when CIA treated splenic cells were isolated and re-exposed to the CIA self-antigen. Overall, this study supports the concurrent and short term, low dose of paKG NPs and methotrexate for the reversal of RA symptoms.